NONOF - Eli Lilly partner BioAge wins $170M to study Zepbound combo
2024-02-13 13:07:35 ET
More on Eli Lilly
- Will Eli Lilly and Company Become A Trillion-Dollar Baby?
- Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade)
- Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript
- Federal judge dismisses PhRMA challenge to Medicare price negotiations
- Booming weight-loss drug market to lift “pick-and-shovel” plays: Jefferies